Assertio Holdings (ASRT) Cash from Investing Activities (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Cash from Investing Activities came in at $15.1 million in Q1 2026, up 614.82% year-on-year from $2.1 million in Q1 2025, and up 789.35% quarter-over-quarter from $1.7 million in Q4 2025.

Assertio Holdings (ASRT) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Cash from Investing Activities across 8 years of filings, most recently posting $15.1 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $15.1 million, up 614.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 111.68% YoY), and the FY2025 annual result was -$12.0 million, up 75.49% from the prior year.
  • Cash from Investing Activities came in at $15.1 million for Q1 2026 at Assertio Holdings, up from $1.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $15.1 million in Q1 2026 to a low of -$43.3 million in Q2 2024.
  • The 5-year median for Cash from Investing Activities is -$553500.0 (2022), against an average of -$5.3 million.
  • Across the five-year window, Cash from Investing Activities surged 1216.98% in 2023 and tumbled 6062.16% in 2024, its largest moves.
  • Assertio Holdings' Cash from Investing Activities stood at -$25.8 million in 2022, then soared by 99.07% to -$239000.0 in 2023, then soared by 567.78% to $1.1 million in 2024, then surged by 51.97% to $1.7 million in 2025, then soared by 789.35% to $15.1 million in 2026.
  • The last three Cash from Investing Activities figures came in at $15.1 million (Q1 2026), $1.7 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 15.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.11 Mn
Mar 31, 2026 15.11 Mn
Dec 31, 2025 1.70 Mn
Dec 31, 2025 1.70 Mn
Sep 30, 2025 -3.81 Mn
Sep 30, 2025 -3.81 Mn
Jun 30, 2025 -6.94 Mn
Jun 30, 2025 -6.94 Mn
Mar 31, 2025 -2.94 Mn
Mar 31, 2025 -2.94 Mn
Dec 31, 2024 1.12 Mn
Dec 31, 2024 1.12 Mn
Sep 30, 2024 -6.71 Mn
Sep 30, 2024 -6.71 Mn
Jun 30, 2024 -43.32 Mn
Jun 30, 2024 -43.32 Mn
Dec 31, 2023 -239,000.00
Dec 31, 2023 -239,000.00
Sep 30, 2023 4.14 Mn
Sep 30, 2023 4.14 Mn